Albeit, this trend was statistically not significant, which is probably due to the fact that in the bisphosphonate arm the population of ER negative patients was limited to 107/1964 patients, whereas in the control arm the proportion of ER negative cancers was markedly higher (135/1684) [37]. Here, ESR1 is linked to cancer.